| Style | Citing Format |
|---|---|
| MLA | Javanmard SH, Heshmatghahdarijani K, Vaseghi G. "Angiotensin-Converting-Enzyme Inhibitors (Ace Inhibitors) and Angiotensin Ii Receptor Blocker (Arb) Use in Covid-19 Prevention or Treatment: A Paradox." Infection Control and Hospital Epidemiology, vol. 42, no. 1, 2021, pp. 118-119. |
| APA | Javanmard SH, Heshmatghahdarijani K, Vaseghi G (2021). Angiotensin-Converting-Enzyme Inhibitors (Ace Inhibitors) and Angiotensin Ii Receptor Blocker (Arb) Use in Covid-19 Prevention or Treatment: A Paradox. Infection Control and Hospital Epidemiology, 42(1), 118-119. |
| Chicago | Javanmard SH, Heshmatghahdarijani K, Vaseghi G. "Angiotensin-Converting-Enzyme Inhibitors (Ace Inhibitors) and Angiotensin Ii Receptor Blocker (Arb) Use in Covid-19 Prevention or Treatment: A Paradox." Infection Control and Hospital Epidemiology 42, no. 1 (2021): 118-119. |
| Harvard | Javanmard SH, Heshmatghahdarijani K, Vaseghi G (2021) 'Angiotensin-Converting-Enzyme Inhibitors (Ace Inhibitors) and Angiotensin Ii Receptor Blocker (Arb) Use in Covid-19 Prevention or Treatment: A Paradox', Infection Control and Hospital Epidemiology, 42(1), pp. 118-119. |
| Vancouver | Javanmard SH, Heshmatghahdarijani K, Vaseghi G. Angiotensin-Converting-Enzyme Inhibitors (Ace Inhibitors) and Angiotensin Ii Receptor Blocker (Arb) Use in Covid-19 Prevention or Treatment: A Paradox. Infection Control and Hospital Epidemiology. 2021;42(1):118-119. |
| BibTex | @article{ author = {Javanmard SH and Heshmatghahdarijani K and Vaseghi G}, title = {Angiotensin-Converting-Enzyme Inhibitors (Ace Inhibitors) and Angiotensin Ii Receptor Blocker (Arb) Use in Covid-19 Prevention or Treatment: A Paradox}, journal = {Infection Control and Hospital Epidemiology}, volume = {42}, number = {1}, pages = {118-119}, year = {2021} } |
| RIS | TY - JOUR AU - Javanmard SH AU - Heshmatghahdarijani K AU - Vaseghi G TI - Angiotensin-Converting-Enzyme Inhibitors (Ace Inhibitors) and Angiotensin Ii Receptor Blocker (Arb) Use in Covid-19 Prevention or Treatment: A Paradox JO - Infection Control and Hospital Epidemiology VL - 42 IS - 1 SP - 118 EP - 119 PY - 2021 ER - |